Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 6OTHER 5OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 89Lung Neoplasms 78Small Cell Lung Carcinoma 28Adenocarcinoma of Lung 8Mesothelioma, Malignant 6Esophageal Neoplasms 6Carcinoma, Hepatocellular 4Adenocarcinoma 4Stomach Neoplasms 3Neoplasm Metastasis 3NSCLC 3Motor Activity 3Mesothelioma 3Meningeal Carcinomatosis 3Carcinoma, Renal Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Thymoma 2Sarcopenia 2Pancreatic Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Melanoma 2Lung Diseases 2EGFR Positive Non-small Cell Lung Cancer 2Disease 2Colorectal Neoplasms 2Weight Loss 1Untreated Advanced Non-small Cell Lung Cancer 1Unresectable Non-small Cell Lung Cancer 1

Interventions

Nutrition Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Weight Loss × Thoracic × Clear all
NCT01048970 2010-01-14

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

National Institute of Cancerología

Phase 2/3 Unknown
120 enrolled
Thoracic

Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡